These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33269686)

  • 1. [Early switch from intravenous to oral antibiotic treatment].
    Buhl CA; Boel JB; Knudsen JD; Horwitz H
    Ugeskr Laeger; 2020 Nov; 182(48):. PubMed ID: 33269686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.
    McMullan BJ; Andresen D; Blyth CC; Avent ML; Bowen AC; Britton PN; Clark JE; Cooper CM; Curtis N; Goeman E; Hazelton B; Haeusler GM; Khatami A; Newcombe JP; Osowicki J; Palasanthiran P; Starr M; Lai T; Nourse C; Francis JR; Isaacs D; Bryant PA;
    Lancet Infect Dis; 2016 Aug; 16(8):e139-52. PubMed ID: 27321363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAIN study: a protocol for a randomised controlled trial evaluating efficacy, safety and cost-effectiveness of intravenous-to-oral antibiotic switch therapy in neonates with a probable bacterial infection.
    Keij FM; Kornelisse RF; Hartwig NG; Mauff K; Poley MJ; Allegaert K; Reiss IKM; Tramper-Stranders GA
    BMJ Open; 2019 Jul; 9(7):e026688. PubMed ID: 31289068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.
    Ahkee S; Smith S; Newman D; Ritter W; Burke J; Ramirez JA
    Pharmacotherapy; 1997; 17(3):569-75. PubMed ID: 9165561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.
    Paladino JA; Sperry HE; Backes JM; Gelber JA; Serrianne DJ; Cumbo TJ; Schentag JJ
    Am J Med; 1991 Nov; 91(5):462-70. PubMed ID: 1951408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral antibiotics for severe infections : an update].
    Tadini E; Masserey-Bonvin V; Emonet S; Petignat PA
    Rev Med Suisse; 2019 Sep; 15(661):1538-1542. PubMed ID: 31496186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study.
    Rodriguez-Pardo D; Pigrau C; Campany D; Diaz-Brito V; Morata L; de Diego IC; Sorlí L; Iftimie S; Pérez-Vidal R; García-Pardo G; Larrainzar-Coghen T; Almirante B
    Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1269-76. PubMed ID: 27180242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early switch of intravenous to oral antibiotic therapy in clinically well neonates with a probable bacterial infection is as effective as a full course of intravenous antibiotics therapy.
    Abdalhady M; Harrison CM
    Arch Dis Child Educ Pract Ed; 2023 Aug; 108(4):290-291. PubMed ID: 37197897
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?
    Landersdorfer CB; Gwee A; Nation RL
    Clin Microbiol Infect; 2023 Sep; 29(9):1120-1125. PubMed ID: 37059222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
    Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
    Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch from intravenous-to-oral antibiotics in neonatal probable and proven early-onset infection: a prospective population-based real-life multicentre cohort study.
    Malchau Carlsen EL; Dungu KHS; Lewis A; Vissing NH; Aunsholt L; Trautner S; Stanchev H; Dayani GK; Pedersen AL; Bjerager M; De Salas M; Vestergaard K; Pedersen P; Frimodt-Møller N; Greisen G; Hansen BM; Nygaard U
    Arch Dis Child Fetal Neonatal Ed; 2023 Dec; 109(1):34-40. PubMed ID: 37369601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review.
    Spellberg B; Chambers HF; Musher DM; Walsh TL; Bayer AS
    JAMA Intern Med; 2020 May; 180(5):769-777. PubMed ID: 32227127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of oral to intravenous antibiotic switch among adult emergency department patients with acute bacterial skin and skin structure infections: a pilot, prospective cohort study.
    Quirke M; Mitchell N; Varley J; Kelly S; Boland F; Moughty A; McKeever J; Fahey T; Wakai A
    BMJ Open; 2020 Aug; 10(8):e034057. PubMed ID: 32868346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early change from intravenous to oral antibiotics: 'switch therapy'].
    Sevinç F; Prins JM; Koopmans RP; Langendijk PN; Dankert J; Speelman P
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2364-9. PubMed ID: 10590775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study.
    de Graaf H; Sukhtankar P; Arch B; Ahmad N; Lees A; Bennett A; Spowart C; Hickey H; Jeanes A; Armon K; Riordan A; Herberg J; Hackett S; Gamble C; Shingadia D; Pallett A; Clarke SC; Henman P; Emonts M; Sharland M; Finn A; Pollard AJ; Powell C; Marsh P; Ballinger C; Williamson PR; Clarke NM; Faust SN
    Health Technol Assess; 2017 Sep; 21(48):1-164. PubMed ID: 28862129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early switch from intravenous to oral antibiotic treatment in bone and joint infections.
    Sendi P; Lora-Tamayo J; Cortes-Penfield NW; Uçkay I
    Clin Microbiol Infect; 2023 Sep; 29(9):1133-1138. PubMed ID: 37182643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement.
    Darley ES; Bannister GC; Blom AW; Macgowan AP; Jacobson SK; Alfouzan W
    J Antimicrob Chemother; 2011 Oct; 66(10):2405-8. PubMed ID: 21742678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
    Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
    BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors' accounts of what influences their clinical practice.
    Broom J; Broom A; Adams K; Plage S
    J Antimicrob Chemother; 2016 Aug; 71(8):2295-9. PubMed ID: 27121400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.